| Original language | English (US) |
|---|---|
| Pages (from-to) | 2343-2348 |
| Number of pages | 6 |
| Journal | Journal of the American College of Cardiology |
| Volume | 60 |
| Issue number | 22 |
| DOIs | |
| State | Published - Dec 4 2012 |
Keywords
- ACCF Health Policy Statements
- cardiovascular disease
- noncommunicable diseases
- prevention
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Journal of the American College of Cardiology, Vol. 60, No. 22, 04.12.2012, p. 2343-2348.
Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Our time
T2 - A call to save preventable death from cardiovascular disease (heart disease and stroke)
AU - Smith, Sidney C.
AU - Collins, Amy
AU - Ferrari, Roberto
AU - Holmes, David R.
AU - Logstrup, Susanne
AU - McGhie, Diana Vaca
AU - Ralston, Johanna
AU - Sacco, Ralph L.
AU - Stam, Hans
AU - Taubert, Kathryn
AU - Wood, David A.
AU - Zoghbi, William A.
N1 - Funding Information: Writing Group Disclosures Writing Group Member Employment Research Grant Other Research Support Speakers' Bureau/Honoraria Expert Witness Ownership Interest Consultant/Advisory Board Other Sidney C. Smith, Jr University of North Carolina None None None None None None None Amy Collins World Heart Federation None None None None None None None Roberto Ferrari University of Ferrara Boehringer Ingelheim † ; Novartis † ; Roche † ; Servier † None Boehringer Ingelheim ⁎ ; Roche ⁎ ; Servier † None None Servier † None David R. Holmes, Jr Mayo Clinic None None None None None None None Susanne Logstrup European Heart Network None None None None None None None Diana Vaca McGhie American Heart Association None None None None None None None Johanna Ralston World Heart Federation None None None None None None None Ralph L. Sacco University of Miami Miller School of Medicine None None None None None None None Hans Stam Dutch Heart Foundation None None None None None None None Kathryn Taubert World Heart Federation None None None None None None None David A. Wood Imperial College London AstraZeneca † ; Bristol-Myers Squibb † ; Emea Sari † ; MSD † ; GlaxoSmithKline † ; Novartis † ; Pfizer Pharmaceuticals † ; Roche † None AstraZeneca ⁎ ; Kowa ⁎ ; MSD ⁎ None MyAction Ltd. † Merck Sharp & Dohme ⁎ None William Zoghbi TMH Physician Organization None None None None None None None This table represents the relationships of writing group members that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all members of the writing group are required to complete and submit. A relationship is considered to be “significant” if 1) the person receives $10,000 or more during any 12-month period, or 5% or more of the person's gross income; or 2) the person owns 5% or more of the voting stock or share of the entity, or owns $10,000 or more of the fair market value of the entity. A relationship is considered to be “modest” if it is less than “significant” under the preceding definition. ⁎ Modest. † Significant.
PY - 2012/12/4
Y1 - 2012/12/4
KW - ACCF Health Policy Statements
KW - cardiovascular disease
KW - noncommunicable diseases
KW - prevention
UR - http://www.scopus.com/inward/record.url?scp=84870217287&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84870217287&partnerID=8YFLogxK
U2 - 10.1016/j.jacc.2012.08.962
DO - 10.1016/j.jacc.2012.08.962
M3 - Article
C2 - 22995536
AN - SCOPUS:84870217287
SN - 0735-1097
VL - 60
SP - 2343
EP - 2348
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
IS - 22
ER -